Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Darwiche, I. Kurth, J. I. Baumbach, U. Sommerwerck, H. Teschler, L. Freitag (Essen, Saarbruecken, Germany). Volatile organic compounds in lung cancer patients before and after tumour resection. Eur Respir J 2011; 38: Suppl. 55, 2790

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds (VOC) in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Fitness before lung resection in lung cancer patients Source: CME Online 2010 Year: 2010 Management of brain metastases in patients with non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Early recurrence in complete resected non-small cell lung cancer patients Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy Source: Eur Respir Rev 2013; 22: 565-576 Year: 2013 Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006 Surgical treatment for lung metastases in patients with colorectal cancer Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 The estimations of two regimenes of radiation of brain metastases in patients with primary lung cancer Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007 Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Refining the breath fingerprint of mesothelioma patients by in vitro identification of cancer cell line-specific volatile metabolites Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Temozolomide in the treatment of brain metastases in lung cancer patients Source: Eur Respir J 2003; 22: Suppl. 45, 65s Year: 2003 Combined resection of adjacent organ in NSCLC Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery Year: 2007 Long-term survival after surgical resection for non-small cell lung cancer Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Brain metastases in lung cancer patients Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients. Year: 2019 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 The survival in elderly patients after resection of lung cancer Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008 Treatment modalities in lung cancer patients with brain metastasis Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Fitness for radical treatment of lung cancer patients Source: Breathe 2011; 7: 221-228 Year: 2011 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012